India Alternatives Investment Advisors Ltd. invested up to USD 8 million for a significant minority stake in Brinton Pharmaceuticals Limited. Brinton is focused on dermatology and has recently expanded into the paediatric dermatology and respiratory segments.
— The Economic Times

DSK Legal advised India Alternatives Private Equity Fund led by a team of partner Hemang Parekh, principal associate Shahin Umani, senior associate Pooja Khanna and associate Supallab Chakraborty.

PDS Legal advised Brinton Pharmaceuticals Limited led by a team of partner Vihang Virkar, executive director Monika Deshmukh and associate Shivani Shah.

2019-06-15

Deal value: INR 55.6 crores